168 related articles for article (PubMed ID: 36768193)
1. Docosahexaenoic Acid-Loaded Nanostructured Lipid Carriers for the Treatment of Peri-Implantitis in Rats.
Li Z; Yin Z; Li B; He J; Liu Y; Zhang N; Li X; Cai Q; Meng W
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768193
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
Seabra CL; Nunes C; Gomez-Lazaro M; Correia M; Machado JC; Gonçalves IC; Reis CA; Reis S; Martins MCL
Int J Pharm; 2017 Mar; 519(1-2):128-137. PubMed ID: 28088639
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
[TBL] [Abstract][Full Text] [Related]
4. The Effects of NF-kB Inhibition with p65-TMD-Linked PTD on Inflammatory Responses at Peri-implantitis Sites.
Jung HJ; Lee W; Shin JS; Lee SK; Lee JH
Inflammation; 2021 Dec; 44(6):2291-2301. PubMed ID: 34169410
[TBL] [Abstract][Full Text] [Related]
5. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
Mussi SV; Sawant R; Perche F; Oliveira MC; Azevedo RB; Ferreira LA; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1882-92. PubMed ID: 24522814
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Prevents the Inflammatory Response in a Ligature-Induced Peri-Implantitis Model: A Canine Study.
He CY; Jiang LP; Wang CY; Zhang Y
Cell Physiol Biochem; 2018; 49(2):610-625. PubMed ID: 30165363
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori biofilms are disrupted by nanostructured lipid carriers: A path to eradication?
Pinho AS; Seabra CL; Nunes C; Reis S; L Martins MC; Parreira P
J Control Release; 2022 Aug; 348():489-498. PubMed ID: 35654169
[TBL] [Abstract][Full Text] [Related]
8. Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy.
Gendy AM; Elnagar MR; Allam MM; Mousa MR; Khodir AE; El-Haddad AE; Elnahas OS; Fayez SM; El-Mancy SS
Biomed Pharmacother; 2022 Jan; 145():112122. PubMed ID: 34489150
[TBL] [Abstract][Full Text] [Related]
9. Mangiferin alleviates experimental peri-implantitis via suppressing interleukin-6 production and Toll-like receptor 2 signaling pathway.
Li H; Chen Z; Zhong X; Li J; Li W
J Orthop Surg Res; 2019 Oct; 14(1):325. PubMed ID: 31623650
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model.
Fernandes RS; Silva JO; Mussi SV; Lopes SCA; Leite EA; Cassali GD; Cardoso VN; Townsend DM; Colletti PM; Ferreira LAM; Rubello D; de Barros ALB
Mol Imaging Biol; 2018 Jun; 20(3):437-447. PubMed ID: 29043471
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation.
Martinez-Micaelo N; González-Abuín N; Terra X; Richart C; Ardèvol A; Pinent M; Blay M
Biochem J; 2012 Jan; 441(2):653-63. PubMed ID: 21954853
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system.
Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW
Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644
[TBL] [Abstract][Full Text] [Related]
14. Role of toll-like receptor 2 in inflammation and alveolar bone loss in experimental peri-implantitis versus periodontitis.
Yu X; Hu Y; Freire M; Yu P; Kawai T; Han X
J Periodontal Res; 2018 Feb; 53(1):98-106. PubMed ID: 28872184
[TBL] [Abstract][Full Text] [Related]
15. Asperuloside Prevents Peri-Implantitis via Suppression of NF-κB and ERK1/2 on Rats.
Wang X; Chen X; Zhang Z; Chen J; Ge Z; Huang S; Wei H; Li D
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015175
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
Zhang R; He GZ; Wang YK; Zhou KG; Ma EL
Nutrition; 2015 Mar; 31(3):508-14. PubMed ID: 25701342
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.
Weldon SM; Mullen AC; Loscher CE; Hurley LA; Roche HM
J Nutr Biochem; 2007 Apr; 18(4):250-8. PubMed ID: 16781858
[TBL] [Abstract][Full Text] [Related]
18. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
[TBL] [Abstract][Full Text] [Related]
19. Redox injectable gel protects osteoblastic function against oxidative stress and suppresses alveolar bone loss in a rat peri-implantitis model.
Ozawa R; Saita M; Sakaue S; Okada R; Sato T; Kawamata R; Sakurai T; Hamada N; Kimoto K; Nagasaki Y
Acta Biomater; 2020 Jul; 110():82-94. PubMed ID: 32348918
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
